'We are information machines - and it's time to renew the code.'

Methuselah Foundation's CEO David Gobel on clinging to the longevity biotech mast while waiting for the rising tide.
September is whizzing by, and that means that it's not long to go until the Longevity Investors Conference takes place in Switzerland. One of the speakers on Day 2 of this must-attend event is the philanthropist, entrepreneur and futurist David Gobel; the Methusaleh Foundation CEO will be presenting on Lifting All Boats... Realizing precision personalized medicine via in vivitro modeling. An in vivitro approach combines traditional in vivo and in vitro methods, creating an 'in life in glass' platform.
Co-founded with Dane Gobel and Aubrey de Grey, the Methuselah Foundation is a medical charity based in Springfield, Virginia. The foundation has invested millions of dollars in the research and development of regenerative medicine, and uses its platform to promote public understanding of longevity and ways to extending the healthy human lifespan.
Visit Longevity.Technology - bit.ly/3PwtH8Y
Follow Longevity.Technology on:
Twitter - bit.ly/3AMIXuq
Facebook - bit.ly/3z8H1v5
Instagram - bit.ly/3IDvVRX
Linkedin - bit.ly/3yIfDmf
More about Longevity Investors Conference: www.longevityinvestors.ch/

[@tombenson5957]

Great interview Phil and Dave!

[@longevity.technology4067]

Thank you!